183 related articles for article (PubMed ID: 35794816)
1. Targeting cancer stemness mediated by BMI1 and MCL1 for non-small cell lung cancer treatment.
Lin EH; Hsu JW; Lee TF; Hsu CF; Lin TH; Jan YH; Chang HY; Cheng CM; Hsu HJ; Chen WW; Chen BH; Tsai HF; Li JJ; Huang CY; Chuang SH; Chang JM; Hsiao M; Wu CW
J Cell Mol Med; 2022 Aug; 26(15):4305-4321. PubMed ID: 35794816
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
[TBL] [Abstract][Full Text] [Related]
3. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
[TBL] [Abstract][Full Text] [Related]
4. Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in
Nangia V; Siddiqui FM; Caenepeel S; Timonina D; Bilton SJ; Phan N; Gomez-Caraballo M; Archibald HL; Li C; Fraser C; Rigas D; Vajda K; Ferris LA; Lanuti M; Wright CD; Raskin KA; Cahill DP; Shin JH; Keyes C; Sequist LV; Piotrowska Z; Farago AF; Azzoli CG; Gainor JF; Sarosiek KA; Brown SP; Coxon A; Benes CH; Hughes PE; Hata AN
Cancer Discov; 2018 Dec; 8(12):1598-1613. PubMed ID: 30254092
[TBL] [Abstract][Full Text] [Related]
5. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
[TBL] [Abstract][Full Text] [Related]
6. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
[TBL] [Abstract][Full Text] [Related]
7. Ring finger 220 promotes the stemness and progression of colon cancer cells via Ubiquitin specific peptidase 22-BMI1 axis.
Yan J; Tan M; Yu L; Jin X; Li Y
Bioengineered; 2021 Dec; 12(2):12060-12069. PubMed ID: 34753387
[TBL] [Abstract][Full Text] [Related]
8. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
9. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
10. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells.
Kabir S; Cidado J; Andersen C; Dick C; Lin PC; Mitros T; Ma H; Baik SH; Belmonte MA; Drew L; Corn JE
Elife; 2019 Jul; 8():. PubMed ID: 31294695
[TBL] [Abstract][Full Text] [Related]
11. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1.
Suzuki J; Nakajima W; Suzuki H; Asano Y; Tanaka N
Biochem Biophys Res Commun; 2017 Jan; 482(4):1334-1340. PubMed ID: 27939888
[TBL] [Abstract][Full Text] [Related]
12. Effects and mechanism of microRNA‑218 against lung cancer.
Chen Y; Yang JL; Xue ZZ; Cai QC; Hou C; Li HJ; Zhao LX; Zhang Y; Gao CW; Cong L; Wang TZ; Chen DM; Li GS; Luo SQ; Yao Q; Yang CJ; Zhu QS; Cao CH
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179084
[TBL] [Abstract][Full Text] [Related]
13. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
[TBL] [Abstract][Full Text] [Related]
14. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.
Oh SJ; Noh KH; Lee YH; Hong SO; Song KH; Lee HJ; Kim S; Kim TM; Jeon JH; Seo JH; Kim DW; Kim TW
Oncotarget; 2015 Nov; 6(37):40255-67. PubMed ID: 26517679
[TBL] [Abstract][Full Text] [Related]
15. Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.
Shi K; Lu H; Zhang Z; Fu Y; Wu J; Zhou S; Ma P; Ye K; Zhang S; Shi H; Shi W; Cai MC; Zhao X; Yu Z; Tang J; Zhuang G
Cell Death Differ; 2023 Jan; 30(1):195-207. PubMed ID: 36171331
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.
Qiu GZ; Mao XY; Ma Y; Gao XC; Wang Z; Jin MZ; Sun W; Zou YX; Lin J; Fu HL; Jin WL
Cancer Sci; 2018 Jul; 109(7):2199-2210. PubMed ID: 29788550
[TBL] [Abstract][Full Text] [Related]
18. MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73.
Widden H; Kaczmarczyk A; Subedi A; Whitaker RH; Placzek WJ
Cell Death Dis; 2020 Nov; 11(11):946. PubMed ID: 33144577
[TBL] [Abstract][Full Text] [Related]
19. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
20. High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients.
Koren A; Rijavec M; Sodja E; Kern I; Sadikov A; Kovac V; Korosec P; Cufer T
Oncotarget; 2017 Apr; 8(15):25384-25394. PubMed ID: 28445986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
